Radiopharmaceuticals Market Energy Guest Posts Industry Industry Analytics Industry Report Market Analytics Market Report Materials Space 

Nuclear Medicine/Radiopharmaceuticals Market Report 2027 Focuses On Top Companies, Research Methodology, Drivers And Opportunities | Cardinal Health, IBA Worldwide, Curium

The global nuclear medicine/radiopharmaceuticals market expected to be US$ 3,982.11 Mn in 2018 and is predicted to grow at a CAGR of 6.2% during the forecast period 2019 – 2027, to reach US$ 6,683.99 Mn by 2027. The market for nuclear medicine/radiopharmaceuticals is expected to grow, owing to factors such as rising prevalence of chronic diseases, alpha radioimmunotherapy-based targeted oncology treatment and advancement in imaging technologies using radiopharmaceuticals play vital role in the growth of the radiopharmaceuticals market. However, the restraints such as short shelf-life of radiopharmaceuticals and availability of…

Read More

Nuclear Medicine-Radiopharmaceuticals Market 2020 Demand with Global Forecast by Top Leading Players: Cardinal Health, Mallinckrodt, GE Healthcare (A Fully-Owned Subsidiary of General Electric Company), Lantheus Medical Imaging, Bayer AG, Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, (A Subsidiary of Sterigenics International LLC.), Advanced Accelerator Applications S.A.

New Jersey, United States: A qualitative research study accomplished by Verified Market Research titled 2020-2026 Global and Regional Nuclear Medicine-Radiopharmaceuticals Market: Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report is the most up to date report which comprises the latest trends that influence the market competition in the forecast period from 2020 to 2026. The report presents different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. Primarily, the report introduces market demands and the present position of…

Read More

Nuclear Medicine/Radiopharmaceuticals Market Detailed Analysis by Size, Status and Forecast 2027

Global nuclear medicine/radiopharmaceuticals market, based on the applications, was segmented as, diagnostic applications and therapeutic applications. In 2018, the diagnostic applications segment held a largest market share of 70.6% of the radiopharmaceuticals market, by applications. This segment is also expected to dominate the market in 2027 owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Moreover, increasing incidences of cardiac diseases, cancer, and neurological disorders are expected to fuel the demand for better diagnosis of these disorders. Also, nuclear medicine provide better…

Read More

Nuclear Medicine/Radiopharmaceuticals Market Key Manufacturers, Development Trends And Competitive Analysis 2027

An exclusive Nuclear Medicine/Radiopharmaceuticals Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by components, end users, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts (key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company‚Äôs website, annual report SEC filing, and paid databases). Further, the market…

Read More